Hyperion DeFi (NASDAQ:HYPD) Stock Rating Lowered by Zacks Research

Hyperion DeFi (NASDAQ:HYPD) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Monday,Zacks.com reports.

Other research analysts have also issued reports about the stock. Cantor Fitzgerald began coverage on shares of Hyperion DeFi in a research note on Tuesday, December 16th. They set an “overweight” rating and a $4.00 target price for the company. Chardan Capital set a $7.75 price objective on Hyperion DeFi and gave the stock a “buy” rating in a report on Wednesday, December 24th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Hyperion DeFi in a research report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $5.88.

Hyperion DeFi Stock Up 7.8%

NASDAQ:HYPD opened at $3.45 on Monday. The company has a current ratio of 2.25, a quick ratio of 2.25 and a debt-to-equity ratio of 0.11. The stock has a 50 day moving average of $3.48 and a 200-day moving average of $5.09. The firm has a market capitalization of $28.19 million, a PE ratio of -0.29 and a beta of 2.74. Hyperion DeFi has a 52 week low of $0.85 and a 52 week high of $17.18.

Hyperion DeFi (NASDAQ:HYPD) last issued its quarterly earnings data on Thursday, March 26th. The company reported ($7.76) EPS for the quarter. The company had revenue of $0.50 million during the quarter. Analysts predict that Hyperion DeFi will post -41.6 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HYPD. Formidable Asset Management LLC acquired a new position in Hyperion DeFi in the fourth quarter worth approximately $83,000. Nations Financial Group Inc. IA ADV acquired a new stake in shares of Hyperion DeFi during the 4th quarter valued at $40,000. Sanctuary Advisors LLC purchased a new stake in shares of Hyperion DeFi during the fourth quarter valued at $38,000. Investment House LLC acquired a new position in shares of Hyperion DeFi in the 4th quarter valued at $166,000. Finally, Geode Capital Management LLC purchased a new position in Hyperion DeFi in the 4th quarter worth about $214,000. 25.84% of the stock is owned by institutional investors and hedge funds.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.